RU2006140092A - COMPOSITIONS AND MIXTURES FOR DELIVERY OF ACTIVE AGENTS - Google Patents
COMPOSITIONS AND MIXTURES FOR DELIVERY OF ACTIVE AGENTS Download PDFInfo
- Publication number
- RU2006140092A RU2006140092A RU2006140092/04A RU2006140092A RU2006140092A RU 2006140092 A RU2006140092 A RU 2006140092A RU 2006140092/04 A RU2006140092/04 A RU 2006140092/04A RU 2006140092 A RU2006140092 A RU 2006140092A RU 2006140092 A RU2006140092 A RU 2006140092A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- active substance
- composition according
- biologically active
- heparin
- Prior art date
Links
- YDQSTNICQDRNFW-UHFFFAOYSA-N CC(C)CCCCCCCC(N(C)c(cc1)ccc1Cl)=O Chemical compound CC(C)CCCCCCCC(N(C)c(cc1)ccc1Cl)=O YDQSTNICQDRNFW-UHFFFAOYSA-N 0.000 description 1
- BCBZVSHIDYGZKV-UHFFFAOYSA-N CC(C)N(C(CCC(O)=O)=O)c1ccccc1 Chemical compound CC(C)N(C(CCC(O)=O)=O)c1ccccc1 BCBZVSHIDYGZKV-UHFFFAOYSA-N 0.000 description 1
- HGBSRFMKEORHMU-UHFFFAOYSA-N CC(CC(O)=O)C(N(C)c(cc1)ccc1Cl)=O Chemical compound CC(CC(O)=O)C(N(C)c(cc1)ccc1Cl)=O HGBSRFMKEORHMU-UHFFFAOYSA-N 0.000 description 1
- ARYGHQHDQAAZRY-UHFFFAOYSA-N CC(CC(O)=O)NC(c1cc(Cl)ccc1O)=O Chemical compound CC(CC(O)=O)NC(c1cc(Cl)ccc1O)=O ARYGHQHDQAAZRY-UHFFFAOYSA-N 0.000 description 1
- XMGSIOAGUJECDZ-UHFFFAOYSA-N CCN(C(CC(C)CC(O)=O)=O)c1ccccc1 Chemical compound CCN(C(CC(C)CC(O)=O)=O)c1ccccc1 XMGSIOAGUJECDZ-UHFFFAOYSA-N 0.000 description 1
- NNVBEDFNGOJPLA-UHFFFAOYSA-N CCN(C(CCCCC(O)=O)=O)c(cc1)ccc1Cl Chemical compound CCN(C(CCCCC(O)=O)=O)c(cc1)ccc1Cl NNVBEDFNGOJPLA-UHFFFAOYSA-N 0.000 description 1
- VWOBAMNFSCYYHA-UHFFFAOYSA-N CN(C(CCCCCCC(O)=O)=O)c(cc1)ccc1F Chemical compound CN(C(CCCCCCC(O)=O)=O)c(cc1)ccc1F VWOBAMNFSCYYHA-UHFFFAOYSA-N 0.000 description 1
- BHBHEDBJGSCBEM-UHFFFAOYSA-N CN(C(CCCCCCC(O)=O)=O)c(cc1)ccc1OC Chemical compound CN(C(CCCCCCC(O)=O)=O)c(cc1)ccc1OC BHBHEDBJGSCBEM-UHFFFAOYSA-N 0.000 description 1
- QJSJXDCPNMFCKF-UHFFFAOYSA-N Cc(cc1)ccc1N(C)C(CCCCC(O)=O)=O Chemical compound Cc(cc1)ccc1N(C)C(CCCCC(O)=O)=O QJSJXDCPNMFCKF-UHFFFAOYSA-N 0.000 description 1
- SYJNIAYOJOFLMS-UHFFFAOYSA-N Cc(cccc1)c1N(C)C(CCCCCCC(O)=O)=O Chemical compound Cc(cccc1)c1N(C)C(CCCCCCC(O)=O)=O SYJNIAYOJOFLMS-UHFFFAOYSA-N 0.000 description 1
- BSPOGRYVBUBWIV-UHFFFAOYSA-N OC(CCNC(c1cc(Cl)ccc1O)=O)=O Chemical compound OC(CCNC(c1cc(Cl)ccc1O)=O)=O BSPOGRYVBUBWIV-UHFFFAOYSA-N 0.000 description 1
- VXMSXBVTUNOSLL-UHFFFAOYSA-N OC(COc(cc1)ccc1OCc1ccccc1)=O Chemical compound OC(COc(cc1)ccc1OCc1ccccc1)=O VXMSXBVTUNOSLL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Соединение, выбранное из:и их солей.2. Состав, содержащий:(A) по меньшей мере одно активное вещество и(B) соединение по п.1.3. Состав по п.2, отличающийся тем, что указанное активное вещество выбрано из группы, включающей биологически активное вещество, химически активное вещество или их комбинацию.4. Состав, по п.2, отличающийся тем, что указанное биологически активное вещество представляет собой по меньшей мере один пептид, мукополисахарид, углевод или липид.5. Состав по п.4, отличающийся тем, что указанное биологически активное вещество представляет собой пептид.6. Состав по п.4, отличающийся тем, что указанное биологически активное вещество представляет собой мукополисахарид.7. Состав по п.2, отличающийся тем, что указанное биологически активное вещество выбрано из группы, включающей:Амилин и протогонисты амилина;Адренокортикотропин;Антигены;Антимикробные препараты, в том числе антибиотики, антибактериальные препараты и антигрибковые препараты; помимо прочего, антибиотики, в том числе грамположительного действия, бактериоцидал, липопептидал и циклические пептидальные антибиотики, такие, как даптомусин (Даптомусин) и его аналоги;Антимигреневые препараты, такие, как BIBM-4096BS и другие белковые антагонисты, генетически родственные кальцитонину, суматриптан сукцинат;Антивирусные препараты, в том числе ацикловир, валацикловир;Предсердный натрийуретический фактор;Бисфосфонаты, в том числе алендронат, хлодронат, этидронат, ибандронат, инкадронат, минодронат, неридронат, олпадронат, памидронат, ризедронат, тилудронат, золедронат, ЕВ1053, и YH529;Кальцитонин, в том числе лосося, морского угря, свиньи и человека;Холецистокини1. A compound selected from: and their salts. 2. A composition comprising: (A) at least one active substance and (B) a compound according to Claim 1.3. The composition according to claim 2, characterized in that said active substance is selected from the group comprising a biologically active substance, a chemically active substance, or a combination thereof. The composition according to claim 2, characterized in that the biologically active substance is at least one peptide, mucopolysaccharide, carbohydrate or lipid. The composition according to claim 4, characterized in that the biologically active substance is a peptide. The composition according to claim 4, characterized in that the biologically active substance is a mucopolysaccharide. The composition according to claim 2, characterized in that the biologically active substance is selected from the group consisting of: Amylin and amylin protogonists; Adrenocorticotropin; Antigens; Antimicrobials, including antibiotics, antibacterial drugs and antifungal drugs; antibiotics, including gram-positive, bacteriocidal, lipopeptidal and cyclic peptide antibiotics, such as daptomusin (Daptomusin) and its analogues; anti-migraine drugs, such as BIBM-4096BS and other protein antagonists, genetically related calcitonin, sumatriptan ; Antiviral drugs, including acyclovir, valacyclovir; Atrial natriuretic factor; Bisphosphonates, including alendronate, chlodronate, ethidronate, ibandronate, incadronate, minodronate, neurronate, olpadronate, pa idronat, risedronate, tiludronate, zoledronate, EV1053, and YH529; calcitonin, including salmon, eel, porcine and human; Holetsistokini
Claims (105)
5-(2-(2-гидроксибензоил)-4-метоксифенокси)валериановая кислота
5- (2- (2-hydroxybenzoyl) -4-methoxyphenoxy) valerianic acid
Applications Claiming Priority (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57131504P | 2004-05-14 | 2004-05-14 | |
US57119504P | 2004-05-14 | 2004-05-14 | |
US57109304P | 2004-05-14 | 2004-05-14 | |
US57114404P | 2004-05-14 | 2004-05-14 | |
US57119404P | 2004-05-14 | 2004-05-14 | |
US57109204P | 2004-05-14 | 2004-05-14 | |
US60/571,151 | 2004-05-14 | ||
US60/571,055 | 2004-05-14 | ||
US60/571,092 | 2004-05-14 | ||
US60/571,194 | 2004-05-14 | ||
US60/571,093 | 2004-05-14 | ||
US60/571,195 | 2004-05-14 | ||
US60/571,315 | 2004-05-14 | ||
US60/571,089 | 2004-05-14 | ||
US60/571,090 | 2004-05-14 | ||
US60/571,144 | 2004-05-14 | ||
US57610504P | 2004-06-01 | 2004-06-01 | |
US60/576,397 | 2004-06-01 | ||
US60/576,088 | 2004-06-01 | ||
US60/576,105 | 2004-06-01 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010133949/04A Division RU2530889C2 (en) | 2004-05-14 | 2005-05-16 | Compounds and formulations for active substance delivery |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2006140092A true RU2006140092A (en) | 2008-06-20 |
RU2403237C2 RU2403237C2 (en) | 2010-11-10 |
Family
ID=44026204
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010133949/04A RU2530889C2 (en) | 2004-05-14 | 2005-05-16 | Compounds and formulations for active substance delivery |
RU2006140092/04A RU2403237C2 (en) | 2004-05-14 | 2005-05-16 | Compositions and mixtures for delivery of active agents |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010133949/04A RU2530889C2 (en) | 2004-05-14 | 2005-05-16 | Compounds and formulations for active substance delivery |
Country Status (1)
Country | Link |
---|---|
RU (2) | RU2530889C2 (en) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3072473A (en) * | 1959-10-07 | 1963-01-08 | Us Rubber Co | Plant growth regulants |
SU1109389A1 (en) * | 1983-05-30 | 1984-08-23 | Институт Органической Химии Ан Армсср | Process for preparing substituted compounds of 4-pyrrolinone-2-s |
US5504244A (en) * | 1986-01-16 | 1996-04-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | Alkylarylketo acids |
CA1338012C (en) * | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
US5354496A (en) * | 1987-07-27 | 1994-10-11 | Elliott Stanley B | Lyotropic liquid crystal salt/inorganic compound complexation products |
US5643957A (en) * | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1996001267A1 (en) * | 1994-07-04 | 1996-01-18 | Takeda Chemical Industries, Ltd. | Phosphonic acid compounds, their production and use |
US5650386A (en) * | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
SI9720025A (en) * | 1996-03-29 | 1999-08-31 | Emishphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1999029640A2 (en) * | 1997-12-05 | 1999-06-17 | Eisai Co., Ltd. | Compositions and methods for modulating the activity of fibroblast growth factor |
ATE288415T1 (en) * | 1999-04-05 | 2005-02-15 | Emisphere Tech Inc | SODIUM SALTS, MONOHYDRATES AND ETHANOL SOLVATES |
IL149336A0 (en) * | 1999-11-05 | 2002-11-10 | Emisphere Tech Inc | Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
ES2298168T3 (en) * | 1999-12-16 | 2008-05-16 | Emisphere Technologies, Inc. | COMPOUNDS AND COMPOSITIONS TO SUPPLY ACTIVE AGENTS. |
US20040077557A1 (en) * | 2000-12-21 | 2004-04-22 | Sulejman Ali | Macrolide antibiotics |
KR100393118B1 (en) * | 2001-02-22 | 2003-07-31 | 현만석 | A method of forming resist patterns in a semiconductor device and a semiconductor washing liquid used in said method |
DE10135027A1 (en) * | 2001-07-18 | 2003-02-06 | Solvay Pharm Gmbh | Use of trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl derivatives in the treatment and / or prophylaxis of Obestias and its concomitant and / or secondary diseases |
WO2004026848A1 (en) * | 2002-09-20 | 2004-04-01 | Lupin Limited | Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents |
-
2005
- 2005-05-16 RU RU2010133949/04A patent/RU2530889C2/en not_active IP Right Cessation
- 2005-05-16 RU RU2006140092/04A patent/RU2403237C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2530889C2 (en) | 2014-10-20 |
RU2403237C2 (en) | 2010-11-10 |
RU2010133949A (en) | 2012-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003513060A5 (en) | ||
IL149337A (en) | Phenoxy carboxylic acid compounds and compositions for delivering active agents | |
JP2002521455A5 (en) | ||
CA2471144A1 (en) | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate | |
CA2421575A1 (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
CA2338419A1 (en) | Pulmonary delivery of active agents | |
JP2007532684A (en) | 8- (2-Hydroxyphenoxy) octyldiethanolamine and its salts for delivery of active agents | |
CA2465641A1 (en) | Phenoxy amine compounds and compositions for delivering active agents | |
Nap et al. | Growth and skeletal development in the dog in relation to nutrition; a review | |
EP2114145B1 (en) | Phenylalkylcarboxylic acid delivery agents | |
MXPA06013251A (en) | Aryl ketone compounds and compositions for delivering active agents. | |
US7411084B2 (en) | Method of preparing phenoxy alkanoic, alkenoic, and alkynoic acids and salts thereof via a dicarboxylate intermediate | |
RU2006140092A (en) | COMPOSITIONS AND MIXTURES FOR DELIVERY OF ACTIVE AGENTS | |
US7129274B1 (en) | Phenoxy carboxylic acid compounds and compositions for delivering active agents | |
US9149530B2 (en) | Compositions and methods for enhancing active agent absorption | |
RU2002114698A (en) | COMPOUNDS OF PHENOXICARBOXYLIC ACID AND COMPOSITIONS FOR DELIVERY OF ACTIVE SUBSTANCES | |
US9458089B2 (en) | Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents | |
ZA200610080B (en) | Compounds and compositions for delivering active agents | |
CA2662853C (en) | Compounds and compositions for delivering active agents | |
EP2150243A2 (en) | Compositions and methods for enhancing active agent absorption | |
RU2001106603A (en) | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF ACTIVE PRODUCTS | |
US20070269494A1 (en) | Compositions and methods for enhancing active agent absorption | |
US20100105604A1 (en) | Allyloxy and alkyloxy benzoic acid delivery agents | |
RU2001105385A (en) | DELIVERY OF ACTIVE MEANS TO LIGHT AND THROUGH LIGHT | |
CN1968919A (en) | 8-(2-hydroxyphenoxy) octyldiethanolamine and salts thereof for delivery of active agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20150517 |